The Swiss provider of dermatology products Galderma is listed on the Swiss stock exchange. The starting price of 53 Swiss francs per share was exceeded by 20.75 per cent on the very first day of trading. This makes it one of the largest IPOs in Europe this year. According to experts, this performance reflects the interest in beauty shares. Galderma, which emerged from a joint venture between L'Oreál and Nestlé, expects significant sales growth in 2023 and 2024.
Further information about Galderma
Further information about Galderma's IPO